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Abstract Various publications stress the importance of
the repeatability (i.e. precision) of the calculation of the
measurement of uncertainty. We reveal by detailing an
example from production control in the pharmaceutical
industry that the effect of other influence quantities should
not be neglected, because their magnitude is even larger
than the contribution of repeatability. We review the role of
repeatability within the calculation of measurement
uncertainty for several common validation and day-to-day
measurement scenarios. They show that measurement
models need to consider the measurement sequences of the
various scenarios. Otherwise the size and effect of the
repeatability might be overestimated. At the end Monte
Carlo simulations were used to investigate the determina-
tion of the repeatability under certain restrictions. The
simulation uncovered a significant bias toward the common
formula for calculating the standard deviation when it is
based on a duplicated measurement of a sample.
Keywords Measurement uncertainty  Repeatability 
Standard deviation  Production control
Introduction
The most recent version of the ISO/IEC/EN 17025 [1]
standard demands that ‘‘Testing laboratories shall have and
shall apply procedures for estimating uncertainty of
measurement... (Clause: 5.4.6.2)’’. Furthermore, numerous
local accreditation bodies require more stringent imple-
mentation of those clauses. Therefore, many analytical
laboratories in industry have started their own efforts to
implement laboratory instructions for estimating the
measurement uncertainty. These calculations are based on
the description of their various measurement procedures [2].
ISO 17025 (2005) [1] suggests in note 3 of clause
5.4.6.3 that the reader use ISO 5725 [3] and the guide to the
expression of uncertainty in measurement (GUM) [4] for
further information. In addition, ILAC [5] recommends
that analytical laboratories use the Eurachem/CITAC guide
‘‘Quantifying Uncertainty in Analytical Measurement 2nd
(QUAM)’’ [6]. These guidelines place emphasis to a
greater or lesser extent on the repeatability, i.e. closeness of
the agreement between the results of repeat measurements
of the same measurand carried out under the same condi-
tions of measurement [7]. This overall performance figure
is often determined either during the method validation or
from the duplicated measurements of the same samples,
which are analysed in the daily routine. Various authors of
different publications point out that according to their
observations repeatability is often the most important
component of the calculation of measurement uncertainty
in analytical chemistry [2, 8–10]. Hence, it is quite
tempting to use only repeatability as a value for measure-
ment uncertainty with the argument that all other compo-
nents do not have a significant impact on the calculation of
the combined standard uncertainty [2]. This attempt is
quite attractive, especially for the industry, which has to
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fulfil new requirements, but wants to achieve them at
minimal costs. For this reason we think it is important to
take a closer look at some aspects of repeatability. Within
the current article we zero in on the detailed measurement
model to check the effect of which influence quantities are
covered by the measured repeatability of the analytical
procedure and which are not. For this purpose we elaborate
on the different details of an example from production
control in the pharmaceutical industry. In addition, we look
at basic statistical principles, which are often neglected for
the calculation of the standard deviation and which might
lead to a considerable underestimation of its value and with
it of measurement uncertainty.
Example: production control in the pharmaceutical
industry
Nowadays, pharmaceutical production often involves more
than ten synthesis steps to obtaining an active agent.
Hence, it is important to control the production efficiency
of each single step within close margins. In addition, the
content of the by-products needs tight monitoring to
exclude any side effects that might be caused by these
impurities. These and other safety risks have led to elab-
orate risk management within a strictly regulated envi-
ronment that places high demands on the validation of
methods and their implementation in the analytical labo-
ratories [11]. We elaborate within this section on a typical
example of an analytical method, which determines the
content of the main product and of all relevant by-products
obtained from a synthesis step.
Due to the highly competitive nature of pharmaceutical
production it is not possible for us to publish any actual
analytical procedures or any performance data, such as
repeatabilities etc. As an alternative we have utilised an
artificial analytical method that is based on numerous
similar methods. These have been examined in detail
during a major project to develop a software product,
which permits the bench chemist to easily calculate mea-
surement uncertainty within a reasonable amount of time
[12]—a much-needed tool, because a large company might
carry out a few thousand analytical procedures that fall
within the scope of ISO 17025.
A syntheses step should result in at least 98% of the
content of the key product and five by-products where the
content should not exceed 2% for one by-product, 0.5% for
two by-products and 0.2% for two by-products. High per-
formance liquid chromatography (HPLC) is the technique
of choice to quantify such compound bodies in pharma-
ceutical industry. The content of the key product is deter-
mined by weighing 100 mg of the product and 100 mg of
its reference substance and then diluting it with 100 ml of
the mobile phase.
The content of each of the 0.5% by-products is quanti-
fied with the same measuring solution of the product that
was used to determine the content of the key product. The
corresponding reference stock solution is produced from
50 mg of the reference standard, which was dissolved in
100 ml of the mobile phase. The measuring solution of the
reference was then produced by diluting 1 ml of the stock
solution with 100 ml of the mobile phase. For the other by-
product the concentration level of the measuring solution
of the reference was adjusted by increasing or decreasing
the amount of weighed reference substance. All the weight
measurements are rounded up or down to 0.1 mg.
Figure 1 shows the flow chart of the analytical proce-
dure. The left side summarises the operations with the
samples, whereas the right side describes the operations
with the reference substance. The additional steps for
diluting the reference solution, which are shown with
dashed lines, are only needed to quantify the by-products.
According to the given information in the specification we
derived the cause and effect diagram of the analytical
procedure using the equation used to calculate the mea-
surement result and the rules developed by Ellison et al.
(Fig. 2) [6, 13].
Before we continue with the discussion of repeatability
issues, we want to have a closer look at the current mea-
Fig. 1 Operating sequence of the analytical procedure to determine
the content of the product and by-products of a synthesis step. Boxes
with dashed lines represent the dilution steps that are needed for the
measurements of the content of the by-product
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surement model displayed as a cause and effect diagram.
The individual measurement operations, which are repre-
sented in the equation used to calculate the measurement
result by different variables, for instance volume, mass,
HPLC measurement and purity, follow all the same
measurement basics summarised in Fig. 3, i.e. comparison
of the sample value with the reference one. The reference
values for the measurement operations in our example,
with the exception of the HPLC measurements, were not
determined in the same laboratory. Therefore, those indi-
vidual models reflect temporal, local and operational dif-
ferences with additional influence quantities. For example,
the filling of the flask considers personal bias by the
operators and possible differences in the formation of the
meniscus due to a different solvent in comparison to the
water, which was used to calibrate the flask.
The HPLC measurements of the reference and sample
signal were made within the same series and on the same
instrument. This leads to a different measurement model,
where possible differences between the sample and refer-
ence measurement and all changes in the reference signal
over time are relevant [12], but no significant systematic
effects that are equal for the sample and reference mea-
surements. Furthermore, in this example both reference and
sample peaks are resolved to base line, which means that
there is no difference between the sample and reference
signal [12].
A feasible measurement scenario for the HPLC is shown
in Fig. 4. After performing the calibration at t = 0 h a
calibration control sample is measured at a given time
interval of t = x h. If the measured value of the calibration
control sample is within a given limit of the value found
during the calibration, then the sample measurements are
continued, otherwise a new calibration is made before
carrying on with the sample measurements.
A typical measurement sequence is displayed in Fig. 5,
where first a reference sample is measured followed by
duplicate measurements of the samples (samples 1, 2 etc.).
The two measurement solutions used for the duplicate
measurements on each sample have been prepared inde-
Fig. 2 Cause and effect
diagram according to the
information of the specification.
No influence quantities have yet
been rearranged. Dashed lines
represent parts of the diagram
that are only relevant for by-
product content determination
Fig. 3 General measurement principle: method for comparing the
sample measurement with the reference measurement
Fig. 4 Calibration control sample: the calibration (A(r) at t = 0)
remains valid as long as any control measurements (A(r) at t = x h)
stay within the given limits
Fig. 5 Measurement sequence for the product and by-product content
determination of a synthesis step
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pendently. Often the laboratories use repeatability, which
was determined from the variation in the duplicate mea-
surements of the same sample, for the calculation of
measurement uncertainty [2, 6]. This practice has direct
implications for the measurement model. We can only
combine those repeatability components of the individual
variables in the measurement equation that can vary
between duplicate measurements of the same sample. The
combination of the influence quantities ‘‘repeatability’’
results in a new branch ‘‘repeatability’’ representing the
overall variation in the results from measurements made of
the same sample. Figure 6 shows the modified cause and
effect diagram for such a measurement protocol. The
repeatability components of all measurement steps related
to the sample are combined to the new main branch
‘‘repeatability’’ in the diagram. Due to the reasons men-
tioned above all the other repeatability components, which
are indicated by a dashed box in the figure, remain with
their individual variables and stay attached to the corre-
sponding main branches. We are of the opinion that this is
an important refinement of the general procedure of com-
bining all repeatability components in the diagram, and has
been described in the Eurachem/CITAC guide [6]. Further
details will be discussed in the next section.
Table 1 summarises the combined standard uncertainty
for the main product and for the five by-product content
determinations assuming 0.35% overall repeatability and
0.3% standard deviation for the HPLC signal of the
measurement solution of the reference. The purity of the
main product can be determined with an expanded
uncertainty of 1.3% (95% confidence level). This means
that the purity of the main product in a given batch has to
be at least 99.3% to pass the requirement of better than
98% to take into account measurement uncertainty. The
expanded uncertainty of the by-product determinations
spans from 1.7 to 2.1% (95% confidence level) depending
on the weighed amount of the reference substance. The
expanded uncertainty with a level of 95% has been
obtained directly from the Monte Carlo distribution
counting from both sides to determine the value of the
appropriate confidence level [12, 14]. If the content of the
main component is calculated by summing the total by-
product content and subtracting it from 100% purity, then
its measurement uncertainty has approximately the same
magnitude as that with the direct content determination.
This value of measurement uncertainty is the combination
of the corresponding measurement uncertainty of all by-
product determinations.
The different contributions of the main branches in the
cause and effect diagram to the overall measurement
uncertainty are shown in Fig. 7. For all investigated cases
the overall repeatability is not the major contribution. It is
the overall performance of the measurements on the HPLC.
One major component is the repeatability of the measure-
ment of the HPLC signal of the reference solution and the
other is the size of the boundaries, which are set on the
control sample before a recalibration is required. It is
important to notice that this variation is not part of the
overall repeatability, because the measurement of the ref-
erence solution was performed only once (see Fig. 5). Its
size has to be determined independently. The pipetting step
to dilute the reference stock solution, which is needed for
the determination of the by-products, is a relevant contri-
bution, because its small volume of 1 ml requires the use of
a micropipette. The weighing of the sample and reference is
of minor importance, except for the content determination
of the lowermost by-product. Here only 20 mg of the ref-
erence standard is weighed to obtain a measurement solu-
tion of the reference within the proper target concentration
and the read-off value is rounded up or down to 0.1 mg.
Fig. 6 Cause and effect
diagram after rearranging some
influence quantities
(repeatabilities) to the new main
branch repeatability, which
represents the variation in the
analytical procedure under
repeatability conditions. Dashed
boxes highlight influence
quantities (repeatabilities),
which cannot be moved due to
the measurement sequence
Table 1 Combined standard uncertainty for the product and by-
products of a synthesis step
Product By-product
1% 0.5% 0.2%
u(c)a (%) 0.63 0.87 0.90 1.10
a Combined standard uncertainty
428 Accred Qual Assur (2007) 12:425–434
123
Aspects of repeatability important for the evaluation
of measurement uncertainty
If we look at the example discussed in the previous section,
then one would expect to be able to develop other mea-
surement scenarios to reduce the value of measurement
uncertainty.
Scenario 1
In a first scenario the value for the repeatability of the
measurement results obtained using the measurement pro-
cedure that has been determined during an in-house vali-
dation study is used in the assessment of uncertainty of
routine measurements. One condition for using the vali-
dation data in this way is the equivalence of the perfor-
mance of the day-to-day measurements to that of the
measurements made during the validation study. There are
different approaches to achieving this objective [15].
The most important performance parameter is the
repeatability of the measurement result. Therefore, one
often observes in the industry the approach to multiplying
the value for the repeatability of the measurement result
determined during the validation study by a factor of 2.8
ð 1:97  ﬃﬃﬃ2p Þ: For the daily routine those duplicated
measurements are then repeated, where the difference be-
tween the two measured values is larger than this previ-
ously set limit. Of course, the measurement models of the
routine analysis and of the validation study have to be the
same for this comparison.
If the two measurement models are not equivalent then
the following pitfall might unintentionally be disregarded.
When performing the validation study all repeatability
contributions of the reference and sample branch (see
Fig. 1) are combined in the overall repeatability of the
measurement result. However, for daily routine work only
the sample branch is repeated when making the duplicated
sample measurement, which means that only the repeat-
ability components of the sample branch contribute to the
repeatability of the measurement result. In this case fewer
repeatability contributions are combined in the repeatabil-
ity of the measurement and therefore its value is most
likely smaller than that obtained during the validation
study. In other words, if we use now the value of the
repeatability of the measurement results determined during
the validation study as a benchmark, then for routine work
the combined repeatability contributions of the sample
branch, which add up to the repeatability of the measure-
ment, are allowed to vary more than during the validation.
This leads of course to a larger overall measurement
uncertainty compared with one calculated using the data
from the validation study. There is an additional pitfall for
this type of benchmarking, which will be discussed in the
last part of this article.
The other, more indirect approaches to ensuring a
similar performance during routine measurements and the
validation study cannot overcome the demand for equiva-
lent measurement models. They often have additional
drawbacks like the system suitability test [16, 17], which is
performed at the beginning of a measurement series and
therefore cannot detect any step by step or sudden deteri-
oration of the actual sample measurements.
Scenario 2
In a second scenario the repeatability of the measurement
result for an interlaboratory study of an analytical proce-
dure that has been determined according to ISO 5725 [3] is
utilised. Here similar arguments are relevant to those in the
previous scenario where the values for the evaluation of
measurement uncertainty were determined during an in-
house validation study. If a laboratory wants to use data
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from an interlaboratory test to derive its measurement
uncertainty, then the study report has to point out in detail
which influence quantities vary between the measurements
made by the individual participants. There needs to be a
detailed measurement model from all the participants
reflecting the measurement sequence and the way to cal-
culate their results. Only under these terms can a laboratory
use the within-laboratory standard deviation (sr) to control
the proper implementation of the validated analytical pro-
cedure. In order to comply with that requirement the lab-
oratory has to conduct the day-to-day analysis using the
same measurement model, which also includes the mea-
surement sequence and the method of calculating the
results. In addition, the same combination of sample and
reference measurements has to be used. If fewer reference
measurements are made then the benchmark repeatability
should be reduced, otherwise a larger standard deviation
could be accepted for fewer repeatability influence quan-
tities combined to form the new main branch representing
the repeatability of the measurement result (see Figs. 5, 6).
Furthermore, under this condition the value of the mea-
surement uncertainty of the day-to-day analysis could be
larger than that derived from the interlaboratory test, which
was conducted at the end of the validation study. It results
in a larger overall measurement uncertainty. We observe
here similar features to those described in the previous
scenario.
Scenario 3
The last scenario is shown in Fig. 8. Two or more reference
measurements, which have been determined over the whole
measurement series, are combined to a mean value ð AðrÞÞ
before the results of the duplicated sample measurements
are calculated. The measurement model here is different
compared with the previous scenarios. Single influence
quantities, which describe the repeatability of individual
steps in the reference branch (see Fig. 1), can now be
moved to the new main branch ‘‘repeatability’’ in the cause
and effect diagram. If all measurement solutions are taken
from the same solution V(r) or V(rf) respectively, then only
the repeatability of the HPLC measurement (A(r)) can be
repositioned. On the other hand, if each measurement
solution of the reference is prepared from scratch using
reference material from at least two manufacturers, who
certify their reference substance independently, then all
influence quantities of the reference branch, which cover
the short-term variation, have to be relocated at the main
branch ‘‘repeatability’’ of the cause and effect diagram.
The current scenario is often representative of a thorough
validation study, which is performed in the specialist re-
search laboratories of a larger company. After that, the
analytical procedure is transferred to field laboratories,
which conduct the day-to-day measurements. The research
centres set up a number of limits that allow monitoring the
proper implementation of the transferred analytical proce-
dure to the field laboratories. One of these limits is set for
the overall repeatability of the measurement results and has
been taken from the extensive validation study. The field
laboratories try to carry out all their measurements at
minimal cost and for that purpose they reduce the total
number of measurements as much as possible by cutting
down the effort for the measurement of the reference
solution. These marginal conditions lead to a measurement
sequence that is most likely not comparable with the
thorough validation study, but with that described for the
example detailed in the previous section. Furthermore, the
measurement models for the day-to-day measurements in
the field laboratories are not the same as for the elaborate
validation study implemented at the research centres.
These conditions can lead to an underestimation of the
overall measurement uncertainty for the day-to-day mea-
surements, when the variation in the duplicated measure-
ments of the same sample is monitored with the limit set by
the results of the validation study. Here we follow the same
arguments described for the previous scenarios.
Duplicated measurements
Finally, we look at the possible direct effects caused by the
determination of the standard deviation from the duplicated
measurements of the same samples on the measurement
uncertainty. It is crucial for the proper quantification of the
repeatability that the system has enough time to vary over
nearly its whole repeatability range between the individual
measurements, i.e. the interval between the two measure-
ments of a duplicate has to be at least as long as the period
of all the major frequencies that compose the repeatability
of the measurement result [18, 19]. If this requirement is
neglected, then the duplicated measurements might be
Fig. 8 Measurement sequence and quantification schema for dupli-
cated measurements of the same sample, which refer to more than one
measurement of the reference during the measurement series
430 Accred Qual Assur (2007) 12:425–434
123
auto-correlated. Such a possible pitfall is the difference
between randomly arranged measurement solutions and a
sequence that was set up in chronological order. To illus-
trate this situation we ran a computer simulation, which is
outlined schematically in Fig. 9. In the simulation we
generate random numbers that follow a normal distribution
with a standard deviation of one. A first random number,
which represents the first measurement, is chosen. Its
location is given by the probability density function (PDF)
of a normal distribution. This normal distribution corre-
sponds to all major frequencies adding up to the repeat-
ability of the measurement result. Then a second random
number is selected, which has to be located within the
limits given by plus and minus half the range (r) from the
position of the first random number. If the second random
number is outside the range, then new random numbers are
generated until one lies inside the given limits. In this way
we simulate two measurements, which take place within a
short amount of time and therefore the whole system has no
chance to vary over the full extent of the normal distribu-
tion. Then the limiting range was broadened step by step
until the range covered six times the standard deviation,
which corresponds for a normal distribution to 99.7% of its
area. At this level the simulation corresponds to a Monte
Carlo method (MCM) of a normal distribution. The results
of the whole simulation process are summarised in Fig. 10.
First we noticed that the calculated mean standard devia-
tion ðsÞ from the duplicated measurements of the same
sample (n = 2) grows gradually, but levels off to a value of
0.75. It never reaches the value of 1, which was used as
input for the standard deviation while generating the nor-
mally distributed random numbers. In other words the
1 million random numbers that form a normal distribution
result in a 25% smaller average standard deviation than the
input value, only because they were paired, and then the
mean standard deviation is calculated from the resulting
500,000 doublets. We repeated the same simulations for
n = 3, 4, 6, 10 and observed a steady approach towards the
expected value of 1. Since this behaviour was not expected,
we started looking for an obvious explanation. First, we
checked the implementation of the simulation in MatLab
[20], but did not find any error. Then we started looking at
some textbooks on statistics and we found in a number of
them [21–23] the explanation we were looking for. The
common formula (Eq. 1), which is generally used to cal-
culate the standard deviation, delivers a biassed estimate of
the standard deviation for small numbers of measurements.
sx ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
n  1
X
n
I¼1
ðxI  xÞ2
s
ð1Þ
with
sx biassed estimate of standard deviation of a single
measurement
n total number of measurements
xI I-th element in the number of measurements with the
value x
x arithmetic mean of the n measurements with values x
The formula (Eq. 2) [22, 23], which delivers an unbiased
estimate of the standard deviation, is of special importance
to small numbers of measurements.
s^x ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n  1
2
r
Cðn1
2
Þ
Cðn
2
Þ sx ð2Þ
with
s^x unbiased estimate of the standard deviation
n total number of measurements
Fig. 9 Schema depicting the determination of the standard deviation
for a duplicated measurement whereby the second measurement has
to be located within given limits. By this means we simulate a system
with a shorter period between the two measurements than the main
variation of the investigated framework
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Fig. 10 Results of the Monte Carlo simulation to determine the mean
standard deviation for n = 2, 3, 4, 6, 10 (n = number of
measurements) with a restricted possibility to vary. The mean
standard deviation for duplicated measurement exhibits the largest
bias at r = 6, whereas it approaches step by step that for an increasing
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G(n) gamma function
sx biassed estimate of the standard deviation of a
single measurement
Table 2 summarises the correction factors that adjust the
values of the biased estimate of the standard deviation to
those of the unbiased one (see Eq. 2). It is strictly only
correct for normally distributed observations. (see Appen-
dix). We were surprised to find that this fact was not
described anywhere in the relevant ISO standards, espe-
cially in ISO 5725 [3].
We have to recall that often bench chemists use the
mean standard deviation of duplicated sample measure-
ments as repeatability of the measurement result (e.g.
Eurachem/CITAC QUAM2002 example 4 [6]) and this
value is biassed according to the results presented above.
Therefore, the effect of the biassed estimate of the standard
deviation on the calculation of measurement uncertainty
should be thoroughly investigated in the near future. As
elaborated previously, the repeatability of an analytical
procedure is an important component, but not the only one,
of the calculation of measurement uncertainty. If the value
of the repeatability is based on a biassed estimate of the
standard deviation due to duplicated measurements of a
sample, and if it builds the largest contribution to the
overall measurement uncertainty, then the combined stan-
dard uncertainty is up to 25% too small, leading to an
expanded uncertainty (k = 2) that is also 25% too small.
This fact has a direct impact on compliance testing and has
considerable consequences when the results are compared
with the given limits of other results. All effects and
resulting consequences of the biassed estimate might not be
that obvious in all cases. For example, the repeatability of
an analytical procedure was determined during an in-house
validation study of ten repeated measurements. The vali-
dation study was designed in such a way that it followed
the same measurement model as that for the day-to-day
measurements of duplicated samples. Hereby, the design
obeys the demands that have been elaborated in the pre-
vious sections of this article. But still the measurement
uncertainty of the day-to-day measurements might be
considerably larger than that calculated from the validation
data, because the biased estimate of the standard deviation
allows the duplicated sample measurements to vary by up
to 22% (see Table 2) more than one would expect from a
limit set up according to the results of the validation study.
Finally, we look at the primary objectives of the simu-
lation after its unexpected aspects have been explained. All
the mean standard deviations (see Fig. 10) show a steady
increase with the increasing size of the range, which limits
the possible location of the second (n = 2) measurement or
each subsequent measurement (n = 3, 4, 6, 10). The lim-
iting value of the mean standard deviation is approximated
to a size of the range r equals four, which corresponds to a
variation between minus and plus two standard deviations.
This means that the interval between the two measurements
of each duplicated sample has to be long enough to allow a
full variation over the whole distribution of the results.
Otherwise, the determined standard deviation is too small
and its value gets larger or even smaller if the timing of the
measurement sequence is prolonged or shortened respec-
tively. This leads to widened boundaries for the acceptance
of results from individual samples. Currently, there are no
propositions or models that allow that effect to be incor-
porated into the calculation of measurement uncertainty.
Conclusion
A number of publications stress the fact that the repeat-
ability of the measurement result obtained using an ana-
lytical procedure is a major contribution to its measurement
uncertainty. A typical example representing production
control in the pharmaceutical industry reveals that other
contributions are at least as important as the repeatability
of the measurement result and that their omission leads to a
significant underestimation of the overall measurement
uncertainty. Furthermore, the standard deviation of an
analytical procedure covers only those influence quantities
that had the possibility to vary during the period of the
individual measurements of the same sample. For this
reason the model of the measurement, which can be elab-
orated as a cause and effect diagram, has to consider the
measurement sequence during the validation study and the
day-to-day measurements. Otherwise, the size of the
measurement uncertainty might be underestimated con-
siderably because performance parameters of a different
nature are compared. Those characteristics are illustrated
describing a number of common validation and day-to-day
measurement scenarios.
Monte Carlo simulations, which were started to
determine the behaviour of the standard deviation from
the duplicated measurement of the same samples under
certainty restrictions, displayed unexpected results. They
Table 2 Correction factor to
adjust the biassed standard
deviation of a given sample size
(n)
Sample size
(n)
Correction
factor
2 1.253314
3 1.128379
4 1.085402
5 1.063846
10 1.028109
15 1.018002
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highlighted the fact that the mean standard deviation
determined from just two measurements of the same
samples is strongly biassed. This bias might lead to an
underestimation of the expanded uncertainty (k = 2) of
up to 25%. In addition, we were able to show with the
help of the simulation that the period between the indi-
vidual measurements of the same sample needs to be
long enough so that the influence quantities, which
comprise the overall repeatability of the analytical pro-
cedure, have enough time to vary over the full range.
Acknowledgement We would like to thank Alex Williams to help
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Appendix
Estimate of the standard deviation
The following deduction was added, because it is relatively
difficult to find it in most textbooks about statistics, and it
is mainly based on [22].
Looking for the density h(s) of the random variable
S ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
n  1
X
n
I¼1
ðXI  XÞ
s
:
The random variable Y ¼ ðn1ÞS2r2 follows a Chi-squared
distribution with n –1 degrees of freedom for a normally
distributed random variable. According to [21] (Chap. IV,
Sect. 5.8.1) the random variable Y holds the density g(y) =
0 for y < 0 and
gðyÞ ¼ 1
2ðn1Þ=2C n1
2
  expð y
2
Þyðn3Þ=2 for y  0:
At first the density w(s2) of the random variable S2 is
determined. In this process s2 is the variable and not s. One
obtains from g(y) with substitution
y ¼ n  1
r2
s2; dy ¼ n  1
r2
ds2
wðs2Þ¼ 1
2
n1
2 C n1
2
 exp ðn1Þs
2
2r2
 
n1
r2
s2
 ðn3Þ=2
n1
r2
¼ ðn1Þ
n1
2
2ðn1Þ=2C n1
2
 
rn1
exp ðn1Þs
2
2r2
 
ðs2Þðn3Þ=2
One obtains from it using the substitution
s¼
ﬃﬃﬃﬃ
s2
p
;s2¼ðsÞ2;ds¼2sds the density h(s) of the random
variable S in the form of
hðsÞ¼ ðn1Þ
ðn1Þ=2
2ðn1Þ=2C n1
2
 
rn1
exp ðn1Þs
2
2r2
 
sn32s
¼ ðn1Þ
ðn1Þ=2
2ðn3Þ=2C n1
2
 
rn1
exp ðn1Þs
2
2r2
 
sn2 for s[0
The expected value of the random variable is obtained
as
EðSÞ ¼
Z
1
0
s hðsÞds
¼ ðn  1Þ
n1
2
2
n3
2 C n1
2
 
rn1
Z
1
0
sn1 exp ðn  1Þs
2
2r2
 
ds
This integral is transformed using the substitution
ðn1Þs2
2r2 ¼ z; s ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2z
n1 r
q
; ðn1Þsr2 ds ¼ dz; ds ¼ rﬃﬃﬃﬃﬃﬃn1p ﬃﬃﬃ2zp dz to
EðSÞ ¼ ðn  1Þ
ðn1Þ=2
2ðn3Þ=2C n1
2
 
rn1
Z
1
0
2r2z
n  1
 
n1
2
 expðzÞ rﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n  1p ﬃﬃﬃﬃ2zp dz
¼
ﬃﬃﬃ
2
p
r
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n  1p C n1
2
 
Z
1
0
z
n
2
1 expðzÞdz
|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
¼Cðn
2
Þ
¼
ﬃﬃﬃ
2
p
C n
2
 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n  1p C n1
2
  r\r
It follows based on the Stirling equation that
lim
n!1
C n
2
 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n  1p C n1
2
  ¼ 1ﬃﬃﬃ
2
p
It is for this reason that
lim
n!1EðsÞ ¼ r
The estimating function S is for r asymptotically unbiased.
Its variance is
VarðSÞ ¼ EðS2Þ  ½EðSÞ2
r2  2C
2 n
2
 
ðn  1ÞC2 n1
2
  r2 ¼ 1  2C
2 n
2
 
ðn  1ÞC2 n1
2
 
 !
r2
The estimating function
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S^ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n  1
2
r
C n1
2
 
C n
2
  S ¼ 1ﬃﬃﬃ
2
p C
n1
2
 
C n
2
 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
X
n
i¼1
ðXI  XÞ2
s
is unbiased with normally distributed random variables and
with any kind of sample size n
EðS^Þ ¼ r;
VarðS^Þ ¼ n  1
2
C2 n1
2
 
C2 n
2
  VarðSÞ ¼ n  1
2
C2 n1
2
 
C2 n
2
   1
 !
r2
with
lim
n!1
n  1
2
C2 n1
2
 
C2 n
2
  ¼ 1:
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